Lonza to co-develop Novartis biologics
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long term strategic partnership that has been struck between the companies.
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long term strategic partnership that has been struck between the companies.
The US Food and Drug Administration (FDA) is launching a quality-by-design (QbD) pilot programme for biotechnology submissions.
Contract research organisation MDS Pharma Services has launched a new version of its ClinQuick electronic data capture (EDC) system designed to help in the design and management of Phase I clinical studies.